|
DDX27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68420000001834E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.620260E-04 |
| Normal-vs-Stage2 |
2.204600E-01 |
| Normal-vs-Stage3 |
2.981600E-03 |
| Normal-vs-Stage4 |
1.219000E-01 |
| Stage1-vs-Stage2 |
3.638200E-01 |
| Stage1-vs-Stage3 |
1.767170E-01 |
| Stage1-vs-Stage4 |
7.323600E-01 |
| Stage2-vs-Stage3 |
9.821800E-02 |
| Stage2-vs-Stage4 |
3.983200E-01 |
| Stage3-vs-Stage4 |
5.791000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09220000002563E-06 |
| Normal-vs-AfricanAmerican |
6.500300E-03 |
| Normal-vs-Asian |
2.138500E-03 |
| Caucasian-vs-AfricanAmerican |
2.298200E-01 |
| Caucasian-vs-Asian |
5.971000E-01 |
| AfricanAmerican-vs-Asian |
2.640800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.5684999999992E-05 |
| Normal-vs-Female |
1.42150000004282E-06 |
| Male-vs-Female |
2.565600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.857900E-02 |
| Normal-vs-Extreme_Weight |
9.957400E-04 |
| Normal-vs-Obese |
2.06859999999365E-05 |
| Normal-vs-Extreme_Obese |
6.372800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.445200E-01 |
| Normal_Weight-vs-Obese |
1.328840E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.488020E-01 |
| Extreme_Weight-vs-Obese |
1.314030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.856500E-02 |
| Obese-vs-Extreme_Obese |
1.858500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.57480000000576E-05 |
| Normal-vs-Age(41-60Yrs) |
1.10919999996018E-06 |
| Normal-vs-Age(61-80Yrs) |
1.079530E-03 |
| Normal-vs-Age(81-100Yrs) |
7.585200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.257840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.760600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.057200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.303600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.270100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.982020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.81219999959315E-07 |
| Normal-VS-Type2 PRCC |
2.254000E-01 |
| Normal-VS-KIRP CIMP |
3.037000E-03 |
| Normal-VS-Unclassified PRCC |
3.435300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.684420E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.105600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.702200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.080700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.869800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.186400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.006400E-02 |
| Normal-vs-N1 |
1.648990E-04 |
| Normal-vs-N2 |
7.893800E-01 |
| N0-vs-N1 |
3.558000E-03 |
| N0-vs-N2 |
6.855600E-01 |
| N1-vs-N2 |
1.094190E-01 |
|
|
